As of Feb 09
| -0.32 / -0.98%|
The 7 analysts offering 12-month price forecasts for Neurocrine Biosciences Inc have a median target of 65.00, with a high estimate of 96.00 and a low estimate of 60.00. The median estimate represents a +101.93% increase from the last price of 32.19.
The current consensus among 7 polled investment analysts is to Buy stock in Neurocrine Biosciences Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.